Concepts (753)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neutrophils | 53 | 2022 | 3797 | 4.680 |
Why?
|
| Wounds and Injuries | 34 | 2022 | 2412 | 2.760 |
Why?
|
| Shock, Hemorrhagic | 24 | 2018 | 248 | 2.700 |
Why?
|
| Receptors, Formyl Peptide | 7 | 2021 | 153 | 2.310 |
Why?
|
| Systemic Inflammatory Response Syndrome | 8 | 2022 | 612 | 2.180 |
Why?
|
| DNA, Mitochondrial | 10 | 2021 | 795 | 1.830 |
Why?
|
| Respiratory Burst | 12 | 2022 | 130 | 1.810 |
Why?
|
| Neutrophil Activation | 11 | 2021 | 199 | 1.740 |
Why?
|
| Mitochondria | 12 | 2022 | 3613 | 1.630 |
Why?
|
| Calcium Signaling | 14 | 2010 | 752 | 1.590 |
Why?
|
| Lung Injury | 6 | 2020 | 399 | 1.560 |
Why?
|
| Chemotaxis | 6 | 2022 | 614 | 1.280 |
Why?
|
| Calcium | 27 | 2018 | 5793 | 1.260 |
Why?
|
| Shock, Traumatic | 7 | 2010 | 30 | 1.180 |
Why?
|
| Sepsis | 5 | 2021 | 2463 | 0.990 |
Why?
|
| Factor VIIa | 4 | 2011 | 98 | 0.980 |
Why?
|
| Chemotaxis, Leukocyte | 7 | 2021 | 700 | 0.930 |
Why?
|
| Chemokines, CXC | 7 | 2004 | 442 | 0.920 |
Why?
|
| Abdominal Injuries | 7 | 2019 | 351 | 0.910 |
Why?
|
| NADH Dehydrogenase | 2 | 2021 | 46 | 0.890 |
Why?
|
| Cross Infection | 4 | 2021 | 1404 | 0.880 |
Why?
|
| Chemotactic Factors | 9 | 2021 | 213 | 0.860 |
Why?
|
| Interleukin-8 | 10 | 2003 | 691 | 0.850 |
Why?
|
| Wounds, Nonpenetrating | 8 | 2018 | 769 | 0.830 |
Why?
|
| Sphingosine | 5 | 2010 | 311 | 0.790 |
Why?
|
| Mitochondrial Proteins | 4 | 2020 | 985 | 0.780 |
Why?
|
| Multiple Trauma | 7 | 2018 | 367 | 0.750 |
Why?
|
| Calcium Channel Blockers | 4 | 2008 | 698 | 0.730 |
Why?
|
| DNA, Bacterial | 3 | 2018 | 1529 | 0.730 |
Why?
|
| Exocytosis | 1 | 2021 | 362 | 0.710 |
Why?
|
| Lysophospholipids | 4 | 2007 | 328 | 0.700 |
Why?
|
| Pneumonia | 6 | 2021 | 2097 | 0.690 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 5 | 2010 | 447 | 0.680 |
Why?
|
| Cytokines | 9 | 2020 | 7190 | 0.680 |
Why?
|
| Capitalism | 1 | 2017 | 9 | 0.670 |
Why?
|
| Professional Corporations | 1 | 2017 | 12 | 0.670 |
Why?
|
| Pneumonia, Bacterial | 2 | 2021 | 315 | 0.660 |
Why?
|
| Femoral Fractures | 5 | 2010 | 369 | 0.610 |
Why?
|
| Toll-Like Receptor 9 | 3 | 2015 | 206 | 0.610 |
Why?
|
| Monocytes | 4 | 2021 | 2627 | 0.590 |
Why?
|
| Rats, Sprague-Dawley | 27 | 2015 | 8525 | 0.580 |
Why?
|
| Trauma Centers | 7 | 2012 | 860 | 0.570 |
Why?
|
| Health Care Sector | 1 | 2017 | 194 | 0.570 |
Why?
|
| Economic Competition | 1 | 2017 | 237 | 0.550 |
Why?
|
| Receptors, Chemokine | 3 | 2004 | 672 | 0.550 |
Why?
|
| Ownership | 1 | 2017 | 324 | 0.540 |
Why?
|
| Shock, Septic | 1 | 2021 | 726 | 0.530 |
Why?
|
| Growth Substances | 7 | 2001 | 811 | 0.530 |
Why?
|
| Phototherapy | 1 | 2017 | 337 | 0.500 |
Why?
|
| Calcium Channels | 3 | 2004 | 650 | 0.490 |
Why?
|
| Hemorrhage | 4 | 2021 | 3278 | 0.480 |
Why?
|
| Nitrendipine | 3 | 2010 | 18 | 0.480 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 6 | 2001 | 1744 | 0.460 |
Why?
|
| Intracranial Hemorrhage, Traumatic | 2 | 2010 | 53 | 0.450 |
Why?
|
| Wounds, Stab | 4 | 2018 | 78 | 0.450 |
Why?
|
| Anthrax | 1 | 2013 | 101 | 0.450 |
Why?
|
| Gastritis | 1 | 2013 | 183 | 0.430 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2017 | 1085 | 0.430 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 4 | 2010 | 717 | 0.430 |
Why?
|
| Coagulants | 1 | 2011 | 53 | 0.420 |
Why?
|
| Shock | 4 | 2010 | 317 | 0.420 |
Why?
|
| Fractures, Bone | 4 | 2015 | 1878 | 0.410 |
Why?
|
| Rats | 29 | 2015 | 24794 | 0.410 |
Why?
|
| Wound Infection | 2 | 2019 | 241 | 0.410 |
Why?
|
| Thoracic Vertebrae | 2 | 2007 | 620 | 0.400 |
Why?
|
| Abdomen | 2 | 2016 | 1099 | 0.400 |
Why?
|
| Lymph | 9 | 2015 | 103 | 0.390 |
Why?
|
| Multiple Organ Failure | 4 | 2018 | 376 | 0.390 |
Why?
|
| Portal Vein | 1 | 2013 | 425 | 0.390 |
Why?
|
| Platelet Activating Factor | 5 | 2005 | 156 | 0.380 |
Why?
|
| General Surgery | 2 | 2020 | 1631 | 0.380 |
Why?
|
| Rhinitis | 1 | 2017 | 663 | 0.380 |
Why?
|
| Inflammation | 8 | 2022 | 10090 | 0.370 |
Why?
|
| Antigens, CD | 6 | 2022 | 4149 | 0.360 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2010 | 499 | 0.360 |
Why?
|
| Capillary Permeability | 2 | 2010 | 846 | 0.350 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2010 | 510 | 0.350 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 5 | 2018 | 228 | 0.350 |
Why?
|
| Sinusitis | 1 | 2017 | 887 | 0.340 |
Why?
|
| Thrombin | 2 | 2010 | 605 | 0.330 |
Why?
|
| Health Care Reform | 1 | 2017 | 1253 | 0.330 |
Why?
|
| Animals | 56 | 2022 | 169173 | 0.330 |
Why?
|
| Humans | 129 | 2022 | 715594 | 0.320 |
Why?
|
| Point-of-Care Systems | 1 | 2016 | 1123 | 0.310 |
Why?
|
| Wounds, Gunshot | 4 | 2019 | 537 | 0.310 |
Why?
|
| Receptors, Interleukin | 2 | 1999 | 245 | 0.310 |
Why?
|
| Killer Cells, Natural | 4 | 2020 | 2168 | 0.300 |
Why?
|
| Wounds, Penetrating | 3 | 2018 | 306 | 0.300 |
Why?
|
| Surgical Wound Infection | 1 | 2016 | 1498 | 0.290 |
Why?
|
| Cresols | 1 | 2005 | 31 | 0.290 |
Why?
|
| Atrial Fibrillation | 2 | 2017 | 4562 | 0.290 |
Why?
|
| Cells, Cultured | 20 | 2018 | 19892 | 0.290 |
Why?
|
| Tomography, Spiral Computed | 2 | 2007 | 290 | 0.290 |
Why?
|
| Membrane Microdomains | 1 | 2007 | 210 | 0.290 |
Why?
|
| Bacteremia | 1 | 2013 | 968 | 0.280 |
Why?
|
| Fractures, Open | 1 | 2006 | 103 | 0.280 |
Why?
|
| Leukocytes, Mononuclear | 5 | 2022 | 1726 | 0.280 |
Why?
|
| Soft Tissue Injuries | 2 | 1997 | 180 | 0.280 |
Why?
|
| Disease Models, Animal | 14 | 2018 | 18175 | 0.280 |
Why?
|
| Cephalosporins | 1 | 2006 | 216 | 0.270 |
Why?
|
| Inflammation Mediators | 5 | 2013 | 1939 | 0.270 |
Why?
|
| Saline Solution, Hypertonic | 2 | 2003 | 113 | 0.270 |
Why?
|
| Reactive Oxygen Species | 3 | 2022 | 2095 | 0.270 |
Why?
|
| Immunity, Innate | 5 | 2018 | 2937 | 0.270 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2005 | 175 | 0.270 |
Why?
|
| Bronchoalveolar Lavage Fluid | 3 | 2015 | 841 | 0.270 |
Why?
|
| Gastrointestinal Diseases | 1 | 2013 | 1157 | 0.260 |
Why?
|
| Endothelium, Vascular | 3 | 2011 | 4586 | 0.260 |
Why?
|
| Exudates and Transudates | 2 | 2022 | 179 | 0.260 |
Why?
|
| Hematoma | 4 | 2018 | 744 | 0.260 |
Why?
|
| Analysis of Variance | 9 | 2014 | 6500 | 0.250 |
Why?
|
| Male | 77 | 2021 | 350143 | 0.250 |
Why?
|
| Acute Lung Injury | 3 | 2013 | 378 | 0.250 |
Why?
|
| Injury Severity Score | 12 | 2008 | 993 | 0.250 |
Why?
|
| Resuscitation | 6 | 2011 | 640 | 0.250 |
Why?
|
| Spectrometry, Fluorescence | 6 | 2010 | 717 | 0.250 |
Why?
|
| Chemokine CXCL1 | 7 | 2018 | 107 | 0.240 |
Why?
|
| HL-60 Cells | 4 | 2005 | 369 | 0.240 |
Why?
|
| Receptors, Leukotriene B4 | 1 | 2003 | 95 | 0.240 |
Why?
|
| Receptor Cross-Talk | 1 | 2003 | 122 | 0.240 |
Why?
|
| Plasma Volume | 2 | 2022 | 40 | 0.240 |
Why?
|
| Estrous Cycle | 1 | 2003 | 66 | 0.230 |
Why?
|
| Endothelial Cells | 6 | 2017 | 3370 | 0.230 |
Why?
|
| Cyclosporine | 2 | 2020 | 816 | 0.230 |
Why?
|
| Craniocerebral Trauma | 3 | 2006 | 474 | 0.230 |
Why?
|
| Mitogen-Activated Protein Kinases | 4 | 2010 | 1307 | 0.230 |
Why?
|
| Peer Review, Health Care | 1 | 2002 | 78 | 0.220 |
Why?
|
| Vascular Diseases | 1 | 2010 | 1141 | 0.220 |
Why?
|
| Endocytosis | 2 | 2004 | 1006 | 0.210 |
Why?
|
| Warfarin | 1 | 2010 | 1476 | 0.210 |
Why?
|
| Paraplegia | 1 | 2002 | 169 | 0.210 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2010 | 4449 | 0.210 |
Why?
|
| Blood Coagulation Disorders | 3 | 2008 | 339 | 0.210 |
Why?
|